Skip to main content
. 2016 Dec 12;16:747. doi: 10.1186/s12879-016-2036-7

Table 1.

Demographic and clinical characteristics of patients with positive isolates for XDRAB

Variable No of patients (%) n = 8
Age (years), mean ± SD 64.5 ± 14.7
Male % 4 (50)
Intrinsic Risk Factors
 Tabagism 3 (37.5)
 Diabetes Mellitus 2 (25)
 Chronic Obstructive Pulmonary Disease 2 (25)
 Previous hospitalization 2 (25)
 Chronic kidney disease 1 (12.5)
 Malignancy 1 (12.5)
 Politrauma 1 (12.5)
 Use of steroid 7 (87.5)
Diagnoses upon admission
 Coronary Artery Disease 2 (25)
 Respiratory Failure 1 (12.5)
 Pulmonary Embolism 1 (12.5)
 Pneumonia 1 (12.5)
 Cancer 1 (12.5)
 Shock 1 (12.5)
 Fracture/Politrauma 1 (12.5)
Site of isolates
 Bronchoalveolar lavage 6 (37.5)
 Endotracheal aspirate 4 (25)
 Central venous blood 2 (12.5)
 Sputum culture 2 (12.5)
 Peripheral venous blood 1 (6.25)
 Rectal swab 1 (6.25)
Device
 Endotracheal tube 8 (100)
 Central venous catheter 8 (100)
 Pleural dreinage 2 (25)
Total Parental Nutrition 5 (62.5)
Previous use of antibiotic in the preceding 90 days
 β-lactam 1 (12.5)
 β-lactam plus another antibiotic 1 (12.5)
 β-lactam plus at least two other categories of antibiotics 6 (75)
 Hospital stay before acquisition of XDRAB (days) 8.3 ± 8.8
 ICU stay before acquisition of XDRAB (days) 9.4 ± 8.8
Clinical significance
 Ventilator associated Pneumonia 6 (75)
 Central venous catheter infection 2 (25)
Outcome
 In-hospital mortality 4 (50)